Literature DB >> 16533116

Vaccine shortages: history, impact, and prospects for the future.

Alan R Hinman1, Walter A Orenstein, Jeanne M Santoli, Lance E Rodewald, Stephen L Cochi.   

Abstract

Vaccine shortages can result from higher-than-expected demand, interruptions in production/supply, or a lack of resources to purchase vaccines. Each of these factors has played a role in vaccine shortages in the United States during the past 20 years. Since 2000, the United States has experienced an unprecedented series of shortages of vaccines recommended for widespread use against 9 diseases, after more than 15 years without vaccine supply problems. In developing countries, the major cause of vaccine shortages is lack of resources to purchase them. Although there are several steps that could reduce the likelihood of future vaccine shortages, many would take several years to implement. Consequently, we will probably continue to see occasional shortages of vaccines in the United States in the next few years.

Mesh:

Substances:

Year:  2006        PMID: 16533116     DOI: 10.1146/annurev.publhealth.27.021405.102248

Source DB:  PubMed          Journal:  Annu Rev Public Health        ISSN: 0163-7525            Impact factor:   21.981


  17 in total

1.  Formulation of microneedles coated with influenza virus-like particle vaccine.

Authors:  Yeu-Chun Kim; Fu-Shi Quan; Richard W Compans; Sang-Moo Kang; Mark R Prausnitz
Journal:  AAPS PharmSciTech       Date:  2010-07-30       Impact factor: 3.246

2.  Lessons Learned From Making and Implementing Vaccine Recommendations in the U.S.

Authors:  L Reed Walton; Walter A Orenstein; Larry K Pickering
Journal:  Am J Prev Med       Date:  2015-08-18       Impact factor: 5.043

3.  Introduction of pentavalent vaccine in Indonesia: a policy analysis.

Authors:  Panji F Hadisoemarto; Michael R Reich; Marcia C Castro
Journal:  Health Policy Plan       Date:  2016-04-23       Impact factor: 3.344

4.  To give or not to give: Approaches to early childhood immunization delivery in Oregon rural primary care practices.

Authors:  Lyle J Fagnan; Scott A Shipman; James A Gaudino; Jo Mahler; Andrew L Sussman; Jennifer Holub
Journal:  J Rural Health       Date:  2011-01-11       Impact factor: 4.333

5.  Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines.

Authors:  Jason B Alarcon; Andrea Waterston Hartley; Noel G Harvey; John A Mikszta
Journal:  Clin Vaccine Immunol       Date:  2007-02-28

6.  Effects of an ongoing epidemic on the annual influenza vaccination rate and vaccination timing among the Medicare elderly: 2000-2005.

Authors:  Byung-Kwang Yoo; Megumi Kasajima; Kevin Fiscella; Nancy M Bennett; Charles E Phelps; Peter G Szilagyi
Journal:  Am J Public Health       Date:  2009-10       Impact factor: 9.308

7.  Antigen-expressing immunostimulatory liposomes as a genetically programmable synthetic vaccine.

Authors:  Maryam Amidi; Markus de Raad; Daan J A Crommelin; Wim E Hennink; Enrico Mastrobattista
Journal:  Syst Synth Biol       Date:  2010-10-26

8.  Variation in hepatitis B immunization coverage rates associated with provider practices after the temporary suspension of the birth dose.

Authors:  Nancy D Lin; Ken Kleinman; K Arnold Chan; Xian-Jie Yu; Eric K France; Feifei Wei; John P Mullooly; Steven Black; David K Shay; Margarette Kolczak; Tracy A Lieu
Journal:  BMC Pediatr       Date:  2006-11-13       Impact factor: 2.125

9.  Identifying the relative priorities of subpopulations for containing infectious disease spread.

Authors:  Shang Xia; Jiming Liu; William Cheung
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

10.  Emergence of event cascades in inhomogeneous networks.

Authors:  Tomokatsu Onaga; Shigeru Shinomoto
Journal:  Sci Rep       Date:  2016-09-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.